SENSEX 74,764.23
NIFTY 23,431.50
CRUDEOIL 9,152.00
+ 418.00
GOLD 153,235.00
The two companies had announced on Monday that NIL had inked an agreement with Pfizer Inc to acquire the trademarks for India, besides certain related intellectual property rights, for ₹1,250 crore
Novartis India acquires Pfizer's Minipress trademarks for ₹1,250 crore; NIL stock surges 20% while Pfizer drops 3.3%. NIL gains mass-market entry in hypertension/BPH treatment, while Pfizer faces ~₹60 crore annual EBITDA decline (4-5% EPS impact).
SENSEX 74,764.23
NIFTY 23,431.50
CRUDEOIL 9,152.00
+ 418.00
GOLD 153,235.00

India Pharma Archives launched at IIM-A, documenting 125 years of India's pharmaceutical industry through rich historical…

Cipla shares soared 3.7% on Friday despite a 39% decline in first-quarter PAT, with the stock trading at ₹1,426.40 on the NSE.

Consolidated net profit in Q1 rises to ₹2,895 crore ($303.54 million) from ₹2,279 crore a year earlier

Sensex Today, Nifty 50 | Stock Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices…

The recent rally in the stock followed the USFDA’s approval for Zaynich (cefepime and zidebactam), an intravenous antibiotic for…

Zydus receives USFDA approval for a surgical imaging drug, Indocyanine Green, with a 180-day exclusivity window for marketing.